Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Fourth-generation vaping devices display a mix of cellular biomarkers indicative of immune suppression

Not all electronic cigarette devices are created equal. Some fourth-generation models – such as Juul devices – are associated with unique changes in markers of immune responses inside our airways.

5 Jul 2022

Researchers explore long-term pulmonary sequelae of SARS-CoV-2 infection in the pediatric population

Researchers described the long-term pulmonary sequelae of COVID-19 in the pediatric population.

5 Jul 2022

Neighborhood ‘redlining’ may increase risk of cardiovascular diseases

The historical discriminatory housing policies known as "redlining" are associated with heart disease and related risk factors today in impacted neighborhoods, more than 60 years after they were banned, according to a study published today in the Journal of the American College of Cardiology.

4 Jul 2022

How does obesity affect the immune system?

A new study summarizes new findings on the immunoregulatory effects of excessive fat stores or malnutrition through Th2 cells.

4 Jul 2022

New discovery could lead to more effective treatments for asthma sufferers

New research led by Edith Cowan University has made an important discovery that could lead to more effective treatments for the world's 262 million asthma sufferers.

4 Jul 2022

AAP recommends breastfeeding for 2 years

The American Academy of Pediatrics recommends that mothers to continue breastfeeding for two years or beyond.

30 Jun 2022

The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics

Researchers assessed the risk of SARS-CoV-2 infection in asthma patients taking biologics.

29 Jun 2022

A cancer patient who had SARS-CoV-2 for over eight months

In a recent study posted to the medRxiv* pre-print server, researchers in Israel described the case of a severely immunocompromised cancer patient who developed a chronic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

28 Jun 2022

Structural racism and inequities linked to higher COVID-19 death rates in Louisiana

Disproportionately high COVID-19 mortality rates among Black populations in Louisiana parishes are the result of longstanding health vulnerabilities associated with institutional and societal discrimination, according to research conducted by an interdisciplinary team under the mentorship of University of Maryland (UMD) Clark Distinguished Chair Deb Niemeier and UMD Associate Professor of Kinesiology Jennifer D. Roberts in the School of Public Health.

27 Jun 2022

Natural and hybrid immunity dynamics in South African mothers

Researchers evaluated natural and hybrid immunity after four COVID-19 waves in South Africa.

24 Jun 2022

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

With the SARS-CoV-2 pandemic ongoing, researchers at University of California San Diego School of Medicine, in collaboration with the American Academy of Allergy Asthma and Immunology, will continue a national study to evaluate the safety of COVID-19 vaccinations during pregnancy, and monitor immune response for mother and baby following vaccinations.

23 Jun 2022

New perspectives on C-section and microbiota in newborns

A new study pinpoints key questions and knowledge gaps that must be addressed in order to define microbiome deficits and their link to health outcomes in infants born by Cesarian section, but also to evaluate adequate clinical intervention strategies in this population.

22 Jun 2022

Childhood bronchitis increases the risk of lung diseases in adult life

Bronchitis in early childhood has been found to increase the risk of lung diseases in middle age according to research from the Allergy and Lung Health Unit at the University of Melbourne.

21 Jun 2022

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

E-cigarettes have become increasingly popular among adolescents, and the latest available scientific evidence suggests the use of these products has adverse health effects that may accrue over time, leading to an increased risk of cardiovascular and pulmonary disease over the course of the life of people who use e-cigarettes, according to a new scientific statement from the American Heart Association published today in the Association's peer-reviewed journal, Circulation: Research.

21 Jun 2022

Asthma News and Research

Further Reading

Fourth-generation vaping devices display a mix of cellular biomarkers indicative of immune suppression

Researchers explore long-term pulmonary sequelae of SARS-CoV-2 infection in the pediatric population

Neighborhood ‘redlining’ may increase risk of cardiovascular diseases

How does obesity affect the immune system?

New discovery could lead to more effective treatments for asthma sufferers

AAP recommends breastfeeding for 2 years

The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics

A cancer patient who had SARS-CoV-2 for over eight months

Structural racism and inequities linked to higher COVID-19 death rates in Louisiana

Natural and hybrid immunity dynamics in South African mothers

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

New perspectives on C-section and microbiota in newborns

Childhood bronchitis increases the risk of lung diseases in adult life

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

Stanford researcher outlines pollution and climate change threats to children's health

MIT researchers design new sensor to distinguish between viral and bacterial pneumonia

Infants in industrialized nations have fewer gut bacteria that efficiently digest breast milk

Covid funding pries open a door to improving air quality in schools

The potential role of Ginkgo biloba L. folium extract in the management of COVID-19

A comparison of SARS-CoV-2 and influenza cytokine storms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News